DOCGO INC Stock Price, News & Analysis

DocGo (Nasdaq:DCGO) reported Q1 2022 revenue of $117.9 million, a remarkable 137% increase from $49.7 million in Q1 2021. The company estimates that $38 million of this revenue came from Covid testing.

Net income improved to $9.4 million, recovering from a $2.0 million loss a year prior. Mobile Health revenue surged to $90.1 million, while medical transport revenue rose by 46% to $27.8 million. The company maintains a revenue guidance of $400-420 million for 2022, projecting annual growth of 25-32%.

DocGo has announced a multi-year contract with Empire BlueCross BlueShield to offer mobile health services to an additional 4.5 million residents in New York. Starting June 1, 2022, this contract will enhance access to in-home medical care for commercial, Medicare, and Medicaid populations. DocGo aims to improve healthcare accessibility outside traditional facilities, aligning with Empire's mission to enhance the health of New Yorkers. This expansion signifies DocGo's growth momentum in the mobile healthcare sector.

DocGo (NASDAQ: DCGO) will report its Q1 results for the period ending March 31, 2022, on May 9, 2022, after market close. An investor conference call is scheduled for May 10, 2022, at 8:30 AM ET. DocGo specializes in last-mile mobile health services and integrated medical transportation, aiming to modernize healthcare delivery. The company highlights its innovative technology and certified professionals that enhance patient care and operational efficiency. Investors can access the call details and webcast through the company's investor relations page.

DocGo has partnered with Jefferson Health to transport the first patient using an all-electric, zero-emissions ambulance, marking a significant milestone in sustainable healthcare solutions. This vehicle, registered as the first of its kind in the U.S., is designed to be 1/10th as polluting as traditional gasoline ambulances. The electric ambulance will begin regular patient transports and is part of DocGo's goal to establish an all-electric fleet by 2032. The collaboration, ongoing since May 2019, aims to improve mobile medical care delivery in the U.S.

DocGo, a leader in mobile health services, will showcase its all-electric, zero-emissions ambulance at the New York International Auto Show from April 15-24, 2022. This innovative ambulance emits only 10% of the pollutants of traditional models, aligning with the company’s commitment to sustainability. DocGo aims for an all-electric fleet by 2032. This exhibition provides an opportunity for attendees to engage with representatives and learn about the future of eco-friendly medical transportation, part of the show's focus on electric vehicles.

DocGo (NASDAQ: DCGO), a leader in last-mile mobile health services, announced that CEO Stan Vashovsky and CFO Andre Oberholzer will present at the 21st Annual Needham Virtual Healthcare Conference on Tuesday, April 12, at 4:30 PM Eastern Time. The event will be accessible via a webcast on the investor relations section of DocGo’s website. DocGo aims to enhance patient care through its integrated medical mobility solutions, bridging physical and virtual healthcare delivery.

DocGo (NASDAQ: DCGO) announces significant growth in the UK through its subsidiary, Ambulnz Community Partners, which has secured three new contracts. These contracts will facilitate the expansion of services into new territories, including East and Central England and Greater Manchester. This initiative aims to enhance patient access to medical transportation, including emergency services and maternity transfers. The company is committed to delivering high-quality healthcare and expanding its international footprint.